Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-416 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D453-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-56 |
filingDate |
2011-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bcf64290adff00a5f4ce48ea02340621 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_821ffbbfe683e5fdd9ef6556b620d842 |
publicationDate |
2012-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-102712600-A |
titleOfInvention |
Process for preparing indazole-3-carboxylic acid and N-(S)-1-azabicyclo[2.2.2]oct-3-yl-1H-indazole-3-carboxamide hydrochloride |
abstract |
[ 2.2.2] Oct-3-yl-1H-indazole-3-carboxamide HCl salt 13 is the key raw material. Nicotinic alpha-7 receptor agonists or partial agonists are useful in the treatment of disease conditions associated with defective or malfunctioning nicotinic acetylcholine receptors, especially in the brain, for example in the treatment of Alzheimer's disease and psychosis Schizophrenia, and other mental and nervous system disorders. The method can be used on scale-up for the preparation of indole-3-carboxylic acid. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109796410-A |
priorityDate |
2010-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |